Search

Your search keyword '"Perrone, S."' showing total 764 results

Search Constraints

Start Over You searched for: Author "Perrone, S." Remove constraint Author: "Perrone, S."
764 results on '"Perrone, S."'

Search Results

1. Comparison of “IN-REC-SUR-E” and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial)

2. AB0918 RETENTION RATE OF SECUKINUMAB IN SPONDYLOARTHRITIS: INSIGHTS FROM A REAL-WORLD STUDY

3. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

4. Immigration and Adverse Pregnancy Outcomes in an Italian Free Care Hospital

5. Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial)

6. Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T)

7. Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study

8. Oral 24% sucrose associated with nonnutritive sucking for pain control in healthy term newborns receiving venipuncture beyond the first week of life

9. Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T)

10. Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial)

11. The uncharted severity of complications after appendectomy for acute appendicitis in children: results from 348 consecutive patients

12. Temporal perception in closed-skill sports: An experimental study on expert swimmers and runners

13. Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study

16. A multidisciplinary approach to estimating wolf population size for long-term conservation

17. Ethics of conducting the study “Oral 24% sucrose associated with nonnutritive sucking for pain control in healthy term newborns receiving venipuncture beyond the first week of life” [Response to Letter]

20. Correction to: The decrease of non-complicated acute appendicitis and the negative appendectomy rate during pandemic (European Journal of Trauma and Emergency Surgery, (2021), 47, 5, (1359-1365), 10.1007/s00068-021-01663-7)

21. The decrease of non-complicated acute appendicitis and the negative appendectomy rate during pandemic

22. P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML

23. P1338: INFUSION OF DIMETHYL SULFOXIDE (DMSO) - DEPLETED AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELLS REDUCES POST-AUTOGRAFTING SEVERE GASTRIC TOXICITIES AND HOSPITALIZATION LENGTH

24. Cardiovascular and renal outcomes with empagliflozin in heart failure

26. Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial

27. Correction to: The decrease of non-complicated acute appendicitis and the negative appendectomy rate during pandemic (European Journal of Trauma and Emergency Surgery, (2021), 47, 5, (1359-1365), 10.1007/s00068-021-01663-7)

28. The decrease of non-complicated acute appendicitis and the negative appendectomy rate during pandemic

29. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

30. Evaluation of the effect of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial

31. Evaluation of the effects of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial

32. Cardiovascular and renal outcomes with empagliflozin in heart failure

33. Management of oxygen saturation monitoring in preterm newborns in the NICU: the Italian picture

34. How to manage children if a second wave of COVID-19 occurs

35. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus

40. Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life

41. Empagliflozin in heart failure with a preserved ejection fraction

44. Heterocycle Synthesis through Pd-Catalyzed Carbonylative Coupling

45. Probing Hadronic Interactions with Measurements at Ultra-High Energies with the Pierre Auger Observatory

46. The Radio Detection of Inclined Showers at the Pierre Auger Observatory

47. Multi-Messenger Studies with the Pierre Auger Observatory

50. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

Catalog

Books, media, physical & digital resources